ArticleAmerican journal of epidemiology2022

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study.

Richeek Pradhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.